DK1259923T3 - Antiinfektionsmiddel, der er anvendeligt mod multilægemiddelresistente bakteriestammer - Google Patents

Antiinfektionsmiddel, der er anvendeligt mod multilægemiddelresistente bakteriestammer

Info

Publication number
DK1259923T3
DK1259923T3 DK01920147T DK01920147T DK1259923T3 DK 1259923 T3 DK1259923 T3 DK 1259923T3 DK 01920147 T DK01920147 T DK 01920147T DK 01920147 T DK01920147 T DK 01920147T DK 1259923 T3 DK1259923 T3 DK 1259923T3
Authority
DK
Denmark
Prior art keywords
drug resistant
bacterial strains
infectious agent
resistant bacterial
against multi
Prior art date
Application number
DK01920147T
Other languages
English (en)
Inventor
Zhenkun Ma
Hong Yong
Peter A Nemoto
Souming Zhang
Yat Sun Or
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1259923T3 publication Critical patent/DK1259923T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DK01920147T 2000-02-24 2001-02-23 Antiinfektionsmiddel, der er anvendeligt mod multilægemiddelresistente bakteriestammer DK1259923T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51223400A 2000-02-24 2000-02-24

Publications (1)

Publication Number Publication Date
DK1259923T3 true DK1259923T3 (da) 2006-05-01

Family

ID=24038243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01920147T DK1259923T3 (da) 2000-02-24 2001-02-23 Antiinfektionsmiddel, der er anvendeligt mod multilægemiddelresistente bakteriestammer

Country Status (9)

Country Link
EP (1) EP1259923B1 (da)
JP (1) JP4025548B2 (da)
AT (1) ATE312839T1 (da)
CA (1) CA2398848C (da)
DE (1) DE60115851T2 (da)
DK (1) DK1259923T3 (da)
ES (1) ES2254389T3 (da)
MX (1) MXPA02008274A (da)
WO (1) WO2001063539A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
GB0225384D0 (en) 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
AU2340797A (en) * 1996-05-07 1997-11-26 Abbott Laboratories 6-o-substituted erythromycins and method for making them
AR023264A1 (es) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical Derivados de eritromicina

Also Published As

Publication number Publication date
MXPA02008274A (es) 2003-01-28
CA2398848A1 (en) 2001-08-30
EP1259923B1 (en) 2005-12-14
JP2004501865A (ja) 2004-01-22
ATE312839T1 (de) 2005-12-15
DE60115851T2 (de) 2006-08-10
WO2001063539A8 (en) 2002-09-19
WO2001063539A3 (en) 2003-03-06
EP1259923A2 (en) 2002-11-27
DE60115851D1 (de) 2006-01-19
ES2254389T3 (es) 2006-06-16
JP4025548B2 (ja) 2007-12-19
CA2398848C (en) 2007-09-25
WO2001063539A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
HUP0400446A2 (hu) Azitromicin kristályformái
NO20055893L (no) Nye linkomycinderivativer med antimikrobiell aktivitet
ES2186916T3 (es) Derivados de isoxazolina como agentes antimicrobianos.
IL189017A0 (en) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents
GB0026924D0 (en) Antibacterial agents
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
UA84879C2 (ru) Изотиазолохинолоны и родственные соединения с противомикробным действием
ATE449775T1 (de) Carbacephem beta-lactam-antibiotika
AR029544A1 (es) Composiciones y metodos para tratar infecciones bacterianas
DK1259923T3 (da) Antiinfektionsmiddel, der er anvendeligt mod multilægemiddelresistente bakteriestammer
BR9914398A (pt) Compostos de hidroxiestilbeno enquanto agentes microbicidas
EA200500353A1 (ru) Производные линкомицина, обладающие антибактериальной активностью
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
MXPA03003434A (es) Panales y panuelos humedos antimicrobianos.
WO2007127218A3 (en) Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
WO2007142725A3 (en) Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof
DK1439840T3 (da) Antibakterielle monobactam-forbindelser og fremgangsmåder til anvendelse heraf
IL183153A0 (en) 8a, 9-DIHYDRO-4a-H-ISOTHIAZOLO[5,4-b]QUINOLINE-3,4-DIONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS
ATE425984T1 (de) Trizyklische antibakterielle makrolidderivate
RU2013147703A (ru) Липосомальный ванкомицин для лечения инфекций мрзс
WO2003068790A3 (en) Macrolide antibacterial compounds
WO2003068791A3 (en) Macrolides with activity against methicillin-resistant staphylococcus aureus
MXPA04005178A (es) Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem.